AstraZeneca (NASDAQ: AZN) has warned it could relocate its vaccine manufacturing site from the UK to the United States as
1 year ago
On Tuesday, the U.S. Food and Drug Administration approved Johnson & Johnson’s (NYSE: JNJ) chemotherapy-free combination treatment for a type
On Thursday, AstraZeneca (NASDAQ: AZN) said the U.S. Food and Drug Administration (FDA) has granted its blockbuster cancer drug Imfinzi
AstraZeneca PLC (NASDAQ: AZN) witnessed a dramatic 8.83% plunge in its share value on Monday following a disappointing update on
3 years ago